FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

Abstract:

:We evaluated primary lung cancers, tumor cell lines, and preneoplastic bronchial lesions for molecular genetic abnormalities in the candidate tumor suppressor gene FHIT, which spans the FRA3B fragile site at 3p14.2. 3p14.2 allele loss was very frequent in 32 lung cancer cell lines [100% of small cell lung cancer and 88% of non-small cell lung cancer (NSCLC)] and 108 primary NSCLC cancers (45%), with numerous breakpoints indicating involvement of several distinct regions in the FRA3B site. 3p14 allele loss was least frequent in the adenocarcinoma subtype and occurred at the relatively late carcinoma in situ stage of preneoplastic bronchial lesions found in NSCLC patients. Homozygous deletions within the FHIT/FRA3B region were found in 6 of 135 (4.4%) thoracic cancer cell lines. Northern blot showed low or absent FHIT expression in most thoracic cancer cell lines tested, whereas reverse transcription-PCR showed that 59-62% exhibited aberrant FHIT transcripts but nearly always (93-100%) also expressing the wild-type transcripts. Aberrant transcripts included precise deletions of FHIT exons, insertion of non-FHIT sequences between exons and insertions replacing exons. Complete open reading frame single-strand conformational polymorphism analysis of 102 lung cancer cDNAs revealed only one nonsplicing mutation. Normal cells including bronchial epithelium, lung, and trachea expressed wild-type FHIT transcript and a variant transcript deleted for exon 8 but not the other aberrant transcripts, arguing against exon 8-deleted FHIT transcripts being tumor specific. Our findings support the conclusion that FHIT/FRA3B abnormalities are associated with lung cancer pathogenesis but that FHIT abnormalities differ from the types of mutations and lack of wild-type transcript found in classic tumor suppressor genes, and functional studies are needed to define the role of FHIT in thoracic tumorigenesis.

journal_name

Cancer Res

journal_title

Cancer research

authors

Fong KM,Biesterveld EJ,Virmani A,Wistuba I,Sekido Y,Bader SA,Ahmadian M,Ong ST,Rassool FV,Zimmerman PV,Giaccone G,Gazdar AF,Minna JD

subject

Has Abstract

pub_date

1997-06-01 00:00:00

pages

2256-67

issue

11

eissn

0008-5472

issn

1538-7445

journal_volume

57

pub_type

杂志文章
  • Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.

    abstract::Antisense DNA has shown an ability to target specific oncogene transcripts and inhibit their expression in cells, but the degree to which sustained treatment can suppress total levels of an oncogenic product and alter tumorigenesis in vivo remains to be determined. In this study, NIH-3T3 cells transformed by the activ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gray GD,Hernandez OM,Hebel D,Root M,Pow-Sang JM,Wickstrom E

    更新日期:1993-02-01 00:00:00

  • Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

    abstract::The mutational spectrum of the p53 gene was analyzed in 53 hepatocellular carcinomas. Somatic mutations of the p53 gene were detected in 17 cases (32%). Among these 17 mutations, 9 were missense mutations; the mutations in the other 8 cases were nonsense mutations, deletions, or mutations at the intron-exon junctions....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nishida N,Fukuda Y,Kokuryu H,Toguchida J,Yandell DW,Ikenega M,Imura H,Ishizaki K

    更新日期:1993-01-15 00:00:00

  • In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.

    abstract::In vivo 31P nuclear magnetic resonance spectroscopy was used to examine the bioenergetics of the rat 9L gliosarcoma during untreated growth and in response to chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Tumor growth was associated with a decline in the phosphocreatine and nucleoside triphosphate resonances...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Steen RG,Tamargo RJ,McGovern KA,Rajan SS,Brem H,Wehrle JP,Glickson JD

    更新日期:1988-02-01 00:00:00

  • Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.

    abstract::Human prostate cancer has a high predisposition to metastasize to bone, resulting in the formation of osteoblastic metastases. The mechanism through which prostate cancer cells promote osteoblastic lesions is undefined. Vascular endothelial growth factor (VEGF) has been implicated as a mediator of osteoblast activity....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-1382

    authors: Dai J,Kitagawa Y,Zhang J,Yao Z,Mizokami A,Cheng S,Nör J,McCauley LK,Taichman RS,Keller ET

    更新日期:2004-02-01 00:00:00

  • Induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide in adult and fetal mice.

    abstract::Pregnancy and development are known to modify carcinogenesis. Little is known about the mechanism for the modulation. These studies investigated the relative sensitivity of nonpregnant, pregnant, and fetal mice to the induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide (...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu LJ,Baxter JR,Wang MY,Harper BL,Tasaka F,Kohda K

    更新日期:1990-10-01 00:00:00

  • Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation.

    abstract::Proteasomal degradation of p53 by human papilloma virus (HPV) E6 oncoprotein plays a pivotal role in the survival of cervical carcinoma cells. Abrogation of HPV-E6-dependent p53 destruction can therefore be a good strategy to combat cervical carcinomas. Here, we show that a small-molecule reactivation of p53 and induc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2787

    authors: Zhao CY,Szekely L,Bao W,Selivanova G

    更新日期:2010-04-15 00:00:00

  • Loss of DCC expression and glioma progression.

    abstract::The deleted in colorectal cancer (DCC) gene, a candidate tumor suppressor gene on chromosome 18q21, encodes a neural cell adhesion molecule family protein that is most highly expressed in the nervous system. To address the hypothesis that DCC may play a role in glioma development and/or progression, we examined DCC ex...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reyes-Mugica M,Rieger-Christ K,Ohgaki H,Ekstrand BC,Helie M,Kleinman G,Yahanda A,Fearon ER,Kleihues P,Reale MA

    更新日期:1997-02-01 00:00:00

  • Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.

    abstract::The steroid hormone 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has potential to be used as an antitumor agent, but its clinical application is restricted by the strong calcemic activity. Therefore, new vitamin D3 analogues are developed with increased growth inhibitory and reduced calcemic activity. In the present study,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vink-van Wijngaarden T,Pols HA,Buurman CJ,van den Bemd GJ,Dorssers LC,Birkenhäger JC,van Leeuwen JP

    更新日期:1994-11-01 00:00:00

  • Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

    abstract::Prostate-specific membrane antigen (PSMA), initially defined by monoclonal antibody (mAb) 7E11, is a now well-characterized type 2 integral membrane glycoprotein expressed in a highly restricted manner by prostate epithelial cells. 7E11 has been shown to bind an intracellular epitope of PSMA that, in viable cells, is ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu H,Moy P,Kim S,Xia Y,Rajasekaran A,Navarro V,Knudsen B,Bander NH

    更新日期:1997-09-01 00:00:00

  • Immunotoxin resistance in multidrug resistant cells.

    abstract::Multidrug resistance (MDR) can be mediated, in part, by overexpression of P-glycoprotein (P-gp) and is characterized by broad resistance to several structurally, chemically, and pharmacologically distinct chemotherapeutic compounds. It has been hypothesized that immunological approaches to cytolysis may be used to ove...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McGrath MS,Rosenblum MG,Philips MR,Scheinberg DA

    更新日期:2003-01-01 00:00:00

  • Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model.

    abstract::Hypoxia inducible factors (HIF) are critical mediators of the cellular response to decreased oxygen tension and are overexpressed in a number of tumors. Although HIF1alpha and HIF2alpha share a high degree of sequence homology, recent work has shown that the two alpha subunits can have contrasting and tissue-specific ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4223

    authors: Bertout JA,Patel SA,Fryer BH,Durham AC,Covello KL,Olive KP,Goldschmidt MH,Simon MC

    更新日期:2009-04-01 00:00:00

  • Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.

    abstract::The alkylating agent temozolomide, commonly used in the treatment of malignant glioma, causes cellular cytotoxicity by forming O(6)-methylguanine adducts. In this report, we investigated whether temozolomide alters the activity of the transcription factor nuclear factor-kappaB (NF-kappaB). Temozolomide inhibits basal ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4496

    authors: Yamini B,Yu X,Dolan ME,Wu MH,Darga TE,Kufe DW,Weichselbaum RR

    更新日期:2007-07-15 00:00:00

  • Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.

    abstract::The identification of proteins that are preferentially expressed on the membrane of metastatic tumor cells is of fundamental importance in cancer research. Here, we report the systematic comparison of the membrane proteome of two closely related murine teratocarcinoma cell lines (F9B9 and F9DR), of which only one (F9D...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0999

    authors: Roesli C,Borgia B,Schliemann C,Gunthert M,Wunderli-Allenspach H,Giavazzi R,Neri D

    更新日期:2009-07-01 00:00:00

  • Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

    abstract::Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status. Therefore, the identification of cancer-associated deregulated signaling pathways is necessary to develop improved targeted therapies. Here, we show that expression of the ceramide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3069

    authors: Heering J,Weis N,Holeiter M,Neugart F,Staebler A,Fehm TN,Bischoff A,Schiller J,Duss S,Schmid S,Korte T,Herrmann A,Olayioye MA

    更新日期:2012-06-01 00:00:00

  • Expression of mammalian paralogues of HRAD9 and Mrad9 checkpoint control genes in normal and cancerous testicular tissue.

    abstract::Human and mouse paralogues of the evolutionarily conserved mammalian HRAD9 and Mrad9 cell cycle checkpoint control genes have been isolated and called HRAD9B and Mrad9B, respectively. HRAD9B encodes a protein that is 414 amino acids long and is 55% similar and 35% identical to the HRAD9 gene product. The Mrad9B protei...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hopkins KM,Wang X,Berlin A,Hang H,Thaker HM,Lieberman HB

    更新日期:2003-09-01 00:00:00

  • Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis.

    abstract::Solid tumors often contain poorly vascularized necrotic regions. In order to determine how such regions are formed within tumors and to identify substances which affect their formation, we have transformed nontumorigenic BALB/c 3T3 cells with an activated Ha-ras oncogene. Cells that were derived from independent clone...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Peretz D,Kimel N,Fujii DK,Neufeld G

    更新日期:1993-01-01 00:00:00

  • Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.

    abstract::Mutations in the parkin gene, which encodes a ubiquitin ligase, are a major genetic cause of parkinsonism. Interestingly, parkin also plays a role in cancer as a putative tumor suppressor, and the gene is frequently targeted by deletion and inactivation in human malignant tumors. Here, we investigated a potential tumo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3060

    authors: Yeo CW,Ng FS,Chai C,Tan JM,Koh GR,Chong YK,Koh LW,Foong CS,Sandanaraj E,Holbrook JD,Ang BT,Takahashi R,Tang C,Lim KL

    更新日期:2012-05-15 00:00:00

  • Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.

    abstract::A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1. We used the mouse mammary tumor virus (MMTV) promoter to target exp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1237

    authors: Kwak EL,Kim S,Zhang J,Cardiff RD,Schmidt EV,Haber DA

    更新日期:2006-02-15 00:00:00

  • Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.

    abstract::Immunohistochemical localization of CA 125 using murine monoclonal antibody OC 125 was performed on fresh frozen tissue from 44 endometrial adenocarcinomas and 26 benign endometria. Immunohistochemical evaluation incorporated both intensity and distribution of staining (CA 125 HSCORE). Thirty-seven cancers (84%) and 2...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berchuck A,Soisson AP,Clarke-Pearson DL,Soper JT,Boyer CM,Kinney RB,McCarty KS Jr,Bast RC Jr

    更新日期:1989-04-15 00:00:00

  • Alterations to DNMT3A in Hematologic Malignancies.

    abstract::In the last decade, large-scale genomic studies in patients with hematologic malignancies identified recurrent somatic alterations in epigenetic modifier genes. Among these, the de novo DNA methyltransferase DNMT3A has emerged as one of the most frequently mutated genes in adult myeloid as well as lymphoid malignancie...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-20-3033

    authors: Venugopal K,Feng Y,Shabashvili D,Guryanova OA

    更新日期:2021-01-15 00:00:00

  • Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.

    abstract::Heat stress may enhance the effect of apoptosis-inducing agents in resistant tumor cells. One such agent is the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which has attracted intense interest for its ability to induce apoptosis in tumors without affecting nonmalignant cells. We therefore tested w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3871

    authors: Pespeni MH,Hodnett M,Abayasiriwardana KS,Roux J,Howard M,Broaddus VC,Pittet JF

    更新日期:2007-03-15 00:00:00

  • Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.

    abstract::Fatty acid synthase (FASN) is the terminal enzyme in de novo lipogenesis and plays a key role in cell proliferation. Pharmacologic inhibitors of FASN are being evaluated in clinical trials for treatment of cancer, obesity, and other diseases. Here, we report a previously unknown mechanism of FASN regulation involving ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1597

    authors: Lin HP,Cheng ZL,He RY,Song L,Tian MX,Zhou LS,Groh BS,Liu WR,Ji MB,Ding C,Shi YH,Guan KL,Ye D,Xiong Y

    更新日期:2016-12-01 00:00:00

  • Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.

    abstract::alpha-Difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase (ODC), was used to select two very highly drug-resistant cell lines, designated K562-DFMOr and V79-DFMOr. Both DFMO-resistant cell lines exhibited elevated ODC expression due to gene amplification. Moreover, the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ask A,Persson L,Rehnholm A,Frostesjö L,Holm I,Heby O

    更新日期:1993-11-01 00:00:00

  • CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.

    abstract::Antitumor type I T-cell responses involving IFN-γ production are critical to control cancer, but the efficacy of this response is limited by a variety of immunosuppressive mechanisms that promote tumoral immune escape. One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-0579

    authors: Redjimi N,Raffin C,Raimbaud I,Pignon P,Matsuzaki J,Odunsi K,Valmori D,Ayyoub M

    更新日期:2012-09-01 00:00:00

  • A measure of genomic instability and its relevance to lymphomagenesis.

    abstract::A recent pilot study that we performed on 12 individuals who are involved in the cultivation and processing of grains and legumes suggests to us that we may have in hand a relatively quick, inexpensive, and highly sensitive assay that identifies individuals at increased risk for the development of lymphoid malignancy....

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Kirsch IR,Lipkowitz S

    更新日期:1992-10-01 00:00:00

  • CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.

    abstract::Neuroblastoma, one of the most common pediatric solid tumors, is characterized by two extreme disease courses, spontaneous regression and life-threatening progression. Here, we conducted a genome-wide search for differences in DNA methylation that distinguish between neuroblastomas of the two types. Three CpG islands ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Abe M,Ohira M,Kaneda A,Yagi Y,Yamamoto S,Kitano Y,Takato T,Nakagawara A,Ushijima T

    更新日期:2005-02-01 00:00:00

  • Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients.

    abstract::We investigated the prognostic value of p53 mutation type for 145 soft tissue sarcoma patients. In a PCR-SSCP-sequencing analysis, 15 mutations were identified: 10 non-frameshift (non-fs) and 5 frameshift (fs) mutations. Patients possessing non-fs mutations had a significantly poorer prognosis than patients without p5...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Taubert H,Meye A,Würl P

    更新日期:1996-09-15 00:00:00

  • Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.

    abstract::Ovarian cancer is mainly confined in peritoneal cavity and its metastasis is often associated with the formation of malignant ascites. As lysophosphatidic acid (LPA) is present at high levels in ascites of ovarian cancer patients and potently stimulates cell migration, we reason that LPA-stimulated cell migration may ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2394

    authors: Chen H,Wu X,Pan ZK,Huang S

    更新日期:2010-12-01 00:00:00

  • Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.

    abstract::Allelic loss of chromosome 9p21 is common in small cell lung cancer (SCLC), but inactivation of the tumor suppressor gene CDKN2a is rare, implying the existence of another target gene at 9p21. A recent deletion mapping study of chromosome 9p has also identified a site of deletion in non-small cell lung cancer (NSCLC) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cairns P,Okami K,King P,Bonacum J,Ahrendt S,Wu L,Mao L,Jen J,Sidransky D

    更新日期:1997-12-01 00:00:00

  • Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.

    abstract::Clonal variants of mouse epidermal JB6 cells that are genetically susceptible (P+) or resistant (P-) to tumor promoter-induced neoplastic transformation exhibit differential activator protein-1 (AP-1) response. Transactivation of AP-1 appears to be necessary but not sufficient to promote transformation in JB6 cells. I...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hsu TC,Nair R,Tulsian P,Camalier CE,Hegamyer GA,Young MR,Colburn NH

    更新日期:2001-05-15 00:00:00